Intracoronary stenting and risk for major adverse cardiac events during the first month

Circulation

Volumn 98, Issue 2, 1998, Pages 104-111

  Schühlen, Helmut ^a   Kastrati, Adnan ^b   Dirschinger, Josef ^b   Hausleiter, Jörg ^b   Elezi, Shpend ^b   Wehinger, Anne ^b   Pache, Jürgen ^b   Hadamitzky, Martin ^b   Schömig, Albert ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Coronary disease; Platelet aggregation inhibitors; Risk factors; Stents

Indexed keywords

HEPARIN; PHENPROCOUMON; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ARTICLE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STENT; THROMBOCYTE AGGREGATION INHIBITION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; UNSTABLE ANGINA PECTORIS;

EID: 0344653648     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.2.104     Document Type: Article

References (28)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701-706.
2. Schömig A, Kastrati A, Mudra H, Blasini R, Schühlen H, Klauss V, Richardt G, Neumann FJ. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation. 1994;90:2716-2724.
3. George BS, Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol ER, Kereiakes DJ, Hartzler GO. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol. 1993;22: 135-143.
4. Pepine CJ, Holmes DR, Block PC, Brikner JA, Mark DB, Mullins CE, Nissen SE, Topol EJ, Williams DO, Goldberg S, Hirshfeld HW, Serruys PW. ACC Expert Consensus Document: coronary artery stents. J Am Coll Cardiol. 1996;28:782-794.
5. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
6. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
7. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, Cleman MW, Cabin HS, Walker C, Stagg J, Buchbinder M, Teirstein PS, Topol EJ, Savage M, Perez JA, Curry RC, Whitworth H, Soussa JE, Tio F, Almagor Y, Ponder R, Penn IM, Leonard B, Levine SL, Fish RD, Palmaz JC. Clinical experience with the Palmaz-Schatz coronary stent: initial results of a multicenler study. Circulation. 1991;83:148-161.
8. Albiero R, Hall P, Itoh A, Blengino S, Nakamura S, Martini G, Ferraro M, Colombo A. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation: comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation. 1997;95:1145-1156.
9. Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulation therapy after coronary stent placement. N Engl J Med. 1996;334:1084-1089.
10. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL. Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
11. Leon MB, Baim DS, Gordon P, Giambartolomei A, Williams DO, Diver DJ, Senerchia C, Fitzpatrick M, Popma JJ, Kuntz RE. Clinical and angiographic results from the Stent Anticoagulation Regimen Study (STARS). Circulation.1996;94(suppl I):I-685. Abstract.
12. Karillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henry M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowski S, Monassier JP, Pernes JM, Rioux P, Spaulding C, Zemour G. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Registry Study. Circulation. 1996; 94:1519-1527.
13. Schühlen H, Hadamitzky M, Walter H, Ulm K, Schömig A. Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial. Circulation. 1997;95:2015-2021.
14. Harrell FE. Predicting Outcomes: Applied Survival Analysis and Logistic Regression. Charlottesville, Va: University of Virginia Press; 1997.
15. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
16. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Pacific Grove, Calif: Wadsworth & Brooks/Cole; 1984.
17. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM, and the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-1202.
18. The Thrombolysis in Myocardial Infarction (TIMI) Trial. N Engl J Med 1985;312:932-936.
19. Agrawal SK, Ho DSW, Liu MW, Iyer S, Hearn JA, Cannon RA, Macander PJ, Dean LS, Baxley WA, Roubin GS. Predictors of thrombotic complications following placement of the flexible coil stent. Am J Cardiol. 1995;73:1216-1219.
20. Liu MW, Voorhees WD III, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intracoronary stenting for threatened or acute closure complicating coronary balloon angioplasty: a Cook registry study. Am Heart J. 1995;130:8-13.
21. Foley JB, Brown RIG, Penn IM. Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting. Am Heart J. 1994;128:12-20.
22. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol. 1997;29:6-12.
23. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol. 1996;27: 494-503.
24. Harker LA, Bruno JB. Ticlopidine's mechanism of action on human platelets. In: Hass WK, Easton JD, eds. Ticlopidine, Platelets and Vascular Disease. New York, NY: Springer; 1993:41-59.
25. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026-2034.
26. Glogar D, Yang P, Hassan A, Heyer G, Klein W, Luha O, Mühlberger V, Maurer E, Pachinger O, Sochor H, Sykora J, Weber H, Weidinger F. Does high-pressure balloon post-dilation improve long-term results of Wiktor coil stent? (Austrian Wiktor Stent Trial). J Am Coll Cardiol. 1997; 29(suppl A):313A. Abstract.
27. Dirschinger J, Schühlen H, Hausleiter J, Elezi S, Boekstegers P, Giehrl W, Pache J, Walter H, Alt E, Neumann FJ, Steinbeck G, Schömig A. A randomized trial of low versus high balloon pressure for coronary stent placement: analysis of early outcome. Circulation. 1997;96(suppl I):I-653. Abstract.
28. Abdelmeguid AE, Topol EJ. The myth of the myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation. 1996;94:3369-3375.